Article Figures & Data
Figures
- Figure 1. PRISMA flow diagram
- Figure 2. Diagram of patient and health professional related themes
Tables
- Table 1. Summary of Sample, Phenomenon of Interest, Design, Evaluation, Research (SPIDER) framework
Sample Health professionals (GPs or nurse practitioners) who prescribe statins or antihypertensive drugs.
Patients eligible for cardiovascular preventive drugs or offered a prescription of statin or an antihypertensive drug for primary prevention of cardiovascular disease.
Phenomenon of Interest The initiation or prescription of statins or antihypertensive drugs. Design Studies including qualitative data collection or analysis methods. Evaluation Attitudes, perceptions, views, or experiences of health professionals or patients related to the initiation of cardiovascular preventive drugs for primary prevention. Research type Qualitative and mixed methods studies. Authors Study title Cardiovascular drug Health professionals,n Patients,n Study design Data collection Data analysis Quality of study UK Gale, 201118 Attitudes of patients and GPs towards medication for primary prevention of CVD after they had received detailed information about CVD risk and the absolute benefits of preventive medicine. Cardiovascular preventive drugs (statin and antihypertensive drugs) 13 17 Qualitative Patients: face to face interviewsGPs: interviews Thematic analysis Good Turner, 201334 Reasons for the variation in statin uptake by high risk patients Statin 4 28 Qualitative Patients: 10 minutes telephone interviews.GPs: 30 minutes face to face interviews. Thematic analysis Fair Virdee, 201332 Primary care physicians’ and practice nurses’ attitude towards using the polypill for CVD prevention Polypill 16 (11 physicians, five practice nurses) – Qualitative Semi-structured interviews and transcribed verbatim. Thematic analysis. Good Virdee, 201533 Patient attitudes about the use of a polypill for CVD prevention Polypill – 17 Qualitative Semi-structured interviews. Thematic analysis. Good Sweden Hultberg, 201231 GPs’ descriptions of their thoughts and actions when prescribing cardiovascular preventive drugs Cardiovascular preventive drugs (no mention of specific drugs) 14 – Qualitative Group interviews of GPs practising together. Qualitative content analysis. Good - CVD
- cardiovascular disease
Item Studies reporting itema Studies reporting item, n (%) Domain 1: Research team and reflexivity Personal characteristics Interviewer/facilitator (18, 31–33) 4 (80) Credentials (33) 1 (20) Occupation (33) 1 (20) Sex – 0 Experience and training (33) 1 (20) Relationship with participants Relationship established – 0 Participant knowledge of the interviewer – 0 Interviewer characteristics – 0 Domain 2: study design Theoretical framework Methodological orientation and theory (31–34) 4 (80) Participant selection Sampling (18, 31–34) 5 (100) Method of approach (18, 31–34) 5 (100) Sample size (18, 31–34) 5 (100) Non-participation (32–34) 3 (60) Setting Setting of data collection (18, 31–34) 5 (100) Presence of non-participants – 0 Description of sample (18, 31–34) 5 (100) Data collection Interview guide (18, 31–34) 5 (100) Repeat interviews (18, 31) 2 (40) Audio/visual recording (18, 31–34) 5(100) Field notes (31–34) 4 (80) Duration (32–34) 3 (60) Data saturation (18, 31–33) 4 (80) Transcripts returned (32, 33) 2 (40) Domain 3: analysis and findings Data analysis Number of data coders (18, 31–33) 4 (80) Description of the coding tree (31–33) 3 (60) Derivation of themes (18, 31–34) 5 (100) Software (32, 33) 2 (40) Participant checking – 0 Reporting Quotations presented (18, 31–34) 5 (100) Data and findings consistent (18, 31–34) 5 (100) Clarity of major themes (18, 31–34) 5 (100) Clarity of minor themes (18, 31–34) 5 (100) aStudies are identified by their reference number.18,31–34
- COREQ
- Consolidated Criteria for Reporting Qualitative Research
Supplementary Data
- bjgpopen20X101087_Supp.pdf -
Supplementary material is not copyedited or typeset, and is published as supplied by the author(s). The author(s) retain(s) responsibility for its accuracy.
In this issue
Patients’ and health professionals’ attitudes and perceptions towards the initiation of preventive drugs for primary prevention of cardiovascular disease: a systematic review of qualitative studies
LinkedIn
Jump to section
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals
